Key Takeaways
-
No single blood panel fits all peptide therapies; the right tests depend on the specific medicine, its approved use, your health history, and your clinician's monitoring plan.
-
For growth-hormone-axis treatment, clinicians commonly review IGF-1, fasting glucose, HbA1c, fasting lipids, and free T4 thyroid markers.
-
Blood work alone cannot diagnose growth hormone deficiency; proper evaluation often requires stimulation testing like the insulin tolerance or glucagon stimulation test.
-
During somatropin dose adjustment, IGF-1 may be checked every 1 to 2 months, then every 6 to 12 months once the dose is stable.
-
Somatropin can worsen insulin resistance or raise blood sugar, so glucose and HbA1c monitoring is especially important for people with diabetes, prediabetes, or related risks.
-
Lab results cannot confirm the quality or safety of a compounded peptide, and FDA materials warn of immunogenicity risks that can occasionally be serious.
Thinking about peptide therapy? You are not alone. More people are asking how to start safely, and the first question is almost always the same: what labs do I need? Here is the honest answer. There is no single, universal blood panel for peptide therapy. The right tests depend on the specific medicine, why it is prescribed, your health history, and your clinician’s monitoring plan.
That said, certain markers come up again and again, especially when a treatment affects the growth hormone axis. In this guide, we walk through five key areas of testing in plain language. Whether you are a data-loving biohacker, a busy professional who wants easy telehealth, or someone simply trying to age well, you will learn what these numbers mean and why they matter. If you want a broader primer first, start with 8 Facts That Explain What Are Peptides in 2026. Then come back here and get comfortable with your lab work. You’ve got this!
Why Lab Work Matters Before Peptide Therapy
Labs give your clinician a snapshot of what is happening inside your body. They help show whether a treatment is a good fit and set a starting point to measure against later. Think of it like a map. You would not start a road trip without knowing where you are.
A smart blood panel for peptide therapy does three jobs:
- Sets a baseline so changes can be tracked over time
- Flags safety concerns like blood sugar problems before they grow
- Guides dosing so your plan is built around you, not a template
One important note: labs help, but they do not tell the whole story. Your symptoms, history, and a clinical exam matter just as much. For a closer look at why numbers should lead the plan, see How to Use Biomarker Testing to Guide Peptide Therapy.
There Is No One-Size-Fits-All Panel
“Peptide therapy” is a big umbrella. It covers many different substances with different purposes. Tests that make sense for a growth-hormone-related medicine may not apply to a peptide used for another goal.
So the best approach is simple. Your provider reviews the specific medicine’s prescribing information and evidence-based guidance, then picks the tests that fit. If anyone offers you one “universal peptide panel” for everything, ask questions.
| Factor | How It Shapes Your Lab Plan |
|---|---|
| Specific peptide or medicine | Each has its own monitoring needs |
| Approved use or indication | Guides which markers matter most |
| Your health history | Diabetes risk, thyroid issues, or heart health can add tests |
| Clinician’s monitoring plan | Sets how often labs are repeated |
5 Blood Tests Commonly Reviewed Before Treatment
Here are the five lab areas that clinicians often look at when planning care around the growth hormone axis. Remember, this is not a checklist for every peptide. Your provider decides what applies to you.
1. IGF-1 (Insulin-Like Growth Factor 1)
IGF-1 is often the star of the show. Your liver makes it in response to growth hormone, so it works as a helpful stand-in for what is going on in that system. For people prescribed somatropin for confirmed growth hormone deficiency, serum IGF-1 is used to guide dose changes.
Here is the catch. A single IGF-1 number does not diagnose anything on its own. Age, sleep, nutrition, and liver health can all nudge it. That is why a clinician reads it alongside your symptoms and history.
2. Fasting Glucose
Fasting glucose shows how much sugar is in your blood after you have not eaten for several hours. Why does this matter? Somatropin can worsen insulin resistance or raise blood sugar in some people. Glucose checks are especially important if you have diabetes, prediabetes, or other diabetes risk factors.
It is a quick, simple test, and it gives your provider an early safety signal.
3. HbA1c
While fasting glucose is a single moment, HbA1c shows your average blood sugar over roughly the past three months. Together, these two give a fuller picture of how your body handles sugar.
Biohackers love this one because it is easy to track over time. If you enjoy watching trends, HbA1c is a great number to follow.
4. Lipid Profile
A lipid profile measures cholesterol and triglycerides. Adult monitoring guidance for growth hormone replacement includes fasting lipids, since body composition and metabolism can shift during treatment.
For aging adults, this test also doubles as a heart health check. It is useful information whether or not you ever start a peptide.
5. Thyroid Testing (Including Free T4)
Your thyroid helps run your energy, mood, and metabolism. Thyroid function can change during growth-hormone-axis treatment, so clinicians may check it at baseline and again later. Free T4 is one of the markers named in adult monitoring guidance.
If you often feel tired, cold, or foggy, thyroid testing is a smart step no matter what. Fatigue has many causes, and your labs can help sort them out.
Quick Reference: Common Baseline Labs
| Lab Test | What It Shows | Why It May Be Checked |
|---|---|---|
| IGF-1 | Growth hormone axis activity | Guides dose adjustments |
| Fasting glucose | Blood sugar at one moment | Safety check for insulin resistance |
| HbA1c | Average blood sugar over about 3 months | Longer-term sugar trends |
| Lipid profile | Cholesterol and triglycerides | Heart and metabolic health |
| Free T4 / thyroid tests | Thyroid function | Energy and metabolism baseline |
Again, these are examples tied to growth-hormone-axis care. Other medicines may call for different tests. Learn more about how lab-first care works in 5 Blood Work Analysis Steps Before Peptides in 2026.
Can a Blood Test Diagnose Growth Hormone Deficiency?
Short answer: no, not by itself. This surprises a lot of people. Clinical guidance calls for a proper diagnostic evaluation for adult growth hormone deficiency, which often includes stimulation testing. The insulin tolerance test and the glucagon stimulation test are two examples cited in guidance.
Why so strict? Growth hormone is released in pulses, so a random blood draw can miss the picture. A low or high IGF-1 reading is a clue, not a verdict.
So if you see an online ad promising a “diagnosis” from one blood draw, take a breath and ask for a real clinical evaluation. A careful provider will walk you through this honestly.
How Often Should Labs Be Repeated?
Monitoring is not one-and-done. According to guidance summarized by the National Library of Medicine, adults taking somatropin for growth hormone deficiency may have IGF-1 checked about every 1 to 2 months during dose titration. Once the dose is stable, checks often move to roughly every 6 to 12 months. You can explore the source material at the National Library of Medicine.
Maintenance assessments may also include fasting glucose, HbA1c, fasting lipids, and free T4. The exact schedule should be set by your treating clinician and tailored to you.
- Baseline labs before treatment begins
- Early follow-up during dose adjustment
- Maintenance checks once your plan is steady
- Extra testing if symptoms or risks change
This rhythm keeps your plan safe and responsive. It also gives you something motivating to watch: real progress, in real numbers.
What About Compounded Peptides?
Here is where we need to be upfront. Lab work is valuable, but it has limits. It cannot confirm the quality or safety of a compounded product.
FDA materials warn that compounded peptides can carry immunogenicity risks. That means your immune system might react to them, and in rare cases the reaction can be serious, including anaphylaxis. The FDA’s October 2024 presentation also notes that routes such as subcutaneous, intravenous, intramuscular, and intradermal may carry greater immunogenicity risk than oral administration. You can read the details in the FDA presentation on compounded peptide immunogenicity.
Compounded products are also not interchangeable with FDA-approved medicines. A normal blood panel does not prove a product is safe. That is why sourcing and provider oversight matter so much. For a deeper comparison, see FDA-Approved vs. Compounded Peptides: What Wins? and Is Peptide Therapy Safe? What You Really Need to Know.
How to Get Ready for Your Blood Draw
A little prep goes a long way. Here are friendly tips to help your results be as useful as possible:
- Follow fasting instructions if your provider asks for fasting glucose or lipids
- Share your full medication and supplement list, including over-the-counter items
- Drink water unless told otherwise, since it makes the draw easier
- Note your symptoms like sleep, energy, and mood so your provider sees the whole picture
- Keep your routine steady the day before, with normal sleep and no extreme workouts
Busy schedule? Many people prefer lab visits close to home. If that sounds like you, take a look at At-Home Blood Work for Hormone Therapy: What to Know.
How Allura Longevity Handles Labs
At Allura Longevity, labs are built into the plan from day one. Clients start with a $50 virtual consultation, then complete blood work through LabCorp. A licensed provider reviews the results and designs a customized six-month plan, with ongoing monitoring and adjustments along the way. Care is led by Ashley, a board-certified Family Nurse Practitioner, and treatment is delivered to your home through telehealth.
That means your plan is shaped around your numbers, not a template. If you are comparing options, the guide How to Start Peptide Therapy Safely and See Real Results is a helpful next read. Allura also offers tailored options through its peptides for women and peptides for men pages.
Putting It All Together
A good blood panel for peptide therapy is personal, not generic. For growth-hormone-axis care, clinicians often review IGF-1, fasting glucose, HbA1c, lipids, and thyroid markers. They repeat testing on a schedule that fits your treatment stage. And they pair every number with a real clinical conversation.
Remember the big takeaways. No single panel fits every peptide. Labs guide care but do not diagnose growth hormone deficiency alone. And no blood test can vouch for the safety of a compounded product. Ask good questions, expect clear answers, and choose a provider who treats you like a person, not a chart.
Ready to take the next step? Spots for new clients are limited each month. Request a consultation with Allura Longevity, or call (813) 510-6277 to talk with the team. Telehealth care is available in Florida, Georgia, Texas, Connecticut, Indiana, Maryland, New York, and California.
FAQs
Q: What blood tests should I get before starting peptide therapy?
A: It depends on the specific peptide and your health history. For growth-hormone-axis treatment, clinicians often review IGF-1, fasting glucose or HbA1c, a lipid profile, and thyroid tests. Your provider will choose the right ones for you.
Q: How often should blood work be checked during peptide therapy?
A: For adults on somatropin for growth hormone deficiency, guidance suggests IGF-1 checks about every 1 to 2 months while the dose is adjusted. After that, checks often happen every 6 to 12 months. Your clinician sets the exact schedule.
Q: Can a blood panel diagnose growth hormone deficiency?
A: No, blood work alone cannot make that diagnosis. Clinical guidance calls for a full evaluation, often including stimulation testing like the insulin tolerance test or glucagon stimulation test. Labs are one helpful piece of the puzzle.
Q: Does peptide therapy affect blood sugar or HbA1c?
A: Some growth-hormone-related treatments, like somatropin, can worsen insulin resistance or raise blood sugar. That is why glucose and HbA1c monitoring matters, especially if you have diabetes, prediabetes, or related risks.
Q: Can lab work tell me if a compounded peptide is safe?
A: Unfortunately, no. Blood tests cannot confirm a compounded product’s quality or safety. The FDA warns that compounded peptides can carry immunogenicity risks, so working with a licensed provider and trusted sourcing is key.
